RPHM
Reneo Pharmaceuticals Inc

624
Loading...
Loading...
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
46

Frequently Asked Questions

What is Market Cap of OnKure Therapeutics Inc.?
What is the 52-week high for OnKure Therapeutics Inc.?
What is the 52-week low for OnKure Therapeutics Inc.?
What is OnKure Therapeutics Inc. stock price today?
What was OnKure Therapeutics Inc. stock price yesterday?
What is the PE ratio of OnKure Therapeutics Inc.?
What is the Price-to-Book ratio of OnKure Therapeutics Inc.?
What is the 50-day moving average of OnKure Therapeutics Inc.?
How many employess does OnKure Therapeutics Inc. has?

Latest RPHM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.